Reported in 2018 by anesthesiologists at the University of Florida College of Medicine in Gainesville, the case suggested a message to TAVR operators: “Vigilance and a high degree of suspicion” are critical for avoiding the potentially severe hemodynamic consequences of HCM associated with aortic stenosis, the authors asserted (J Med Case Rep 2018;18;12[1]:372).

There’s a reason to feel quite optimistic about these numbers—the rise comes from an updated definition of hypertension, one first suggested by the American College of Cardiology and American Heart Association.

The high mortality rates from COVID-19 among black patients and other racial/ethnic minorities put a much-needed spotlight on the “deep-rooted failures” of the U.S. healthcare system to improve care for cardiovascular disease (CVD), according to a new commentary.

The first known death from COVID-19 in the United States was caused by a ventricular rupture.  

Taking evolocumab to lower LDL cholesterol can lead to significant reductions in a patient’s risk of myocardial infarction (MI), according to new findings published by JAMA Cardiology.

The company announced the service launch April 28, saying individuals who want the test can request it online—cost: $119—without referral from a doctor.

SIIM said the decision was influenced by both continued travel restrictions among its members and a desire to quell the spread of COVID-19. 

Governments around the world have their own COVID contact-tracing apps already up and running—and several U.S. states have indicated they like their own solutions just fine.